NSC |
Compound |
Enrichment |
Correlation |
NSC 670163 |
Null |
0.0152619242759634 |
0.00037795972 |
NSC 675253 |
Null |
0.0152619242759634 |
0.41701924 |
NSC 689529 |
Null |
0.0152619242759634 |
0.54171322 |
NSC 696661 |
(6R,6S)-2,4-Diamino-6-(3,4,5-trimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline |
0.0152619242759636 |
0.36249504 |
NSC 700325 |
Null |
0.0152619242759636 |
0.30023618 |
NSC 728509 |
1-(2-Benzylthio-4-chloro-5-phenylcarbamoylbenzenesulfonyl)-3 -(2-oxobutane-3-ylideneimino)guanidine |
0.0152619242759636 |
0.30570139 |
NSC 760289 |
3-hydroxy-8,9-dimethoxy-isoindolo[2,1a]quinoxalin-6-(5H)-imino |
0.0152619242759636 |
0.35053017 |
NSC 107124 |
Camptothecin Derivative |
0.0179905510964914 |
0.48762477 |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.0179905510964914 |
0.13544984 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0179905510964914 |
0.41699925 |